Core mutations, IL28B polymorphisms and response to peginterferon/ribavirin treatment in Swedish patients with hepatitis C virus genotype 1 infection

BACKGROUND: Patients infected with hepatitis C virus (HCV) genotype 1 respond poorly to standard treatment with 50% or less achieving sustained virologic response. Predicting outcome is essential and could help avoid unnecessary treatment and reduce health cost. Recently, an association of amino aci...

Descripción completa

Detalles Bibliográficos
Autores principales: Alestig, Erik, Arnholm, Birgitta, Eilard, Anders, Lagging, Martin, Nilsson, Staffan, Norkrans, Gunnar, Wahlberg, Thomas, Wejstål, Rune, Westin, Johan, Lindh, Magnus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3112098/
https://www.ncbi.nlm.nih.gov/pubmed/21569441
http://dx.doi.org/10.1186/1471-2334-11-124

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3112098/
https://www.ncbi.nlm.nih.gov/pubmed/21569441
http://dx.doi.org/10.1186/1471-2334-11-124

Ejemplares similares